logo

For the Inventor, By the Inventor

Huw M L Davies

Duluth, GA, United States of America

Huw M L Davies

LinkedIn

This inventor holds 18 USPTO granted patents and 2 published patent applications and 2 EPO patents, primarily in Central Nervous System. Top assignees: The State University of New York, Emory University, Chakra Biotech Pte Ltd.. Active years: 2002-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huw M L Davies. Retrieved from https://idiyas.com/inventor/huw-m-l-davies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 44.4


Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Clarence Center, NY (US) (2002 - 2006)
  • E. Amherst, NY (US) (2008 - 2010)
  • East Amherst, NY (US) (2008 - 2010)
  • Duluth, GA (US) (2012 - 2019)

Company Filing History:

goldMedal14 out of 2,046 
 
The State University of New York
 patents
silverMedal4 out of 1,024 
 
Emory University
 patents
bronzeMedal1 out of 1 
 
Chakra Biotech Pte Ltd.
 patent
4. 1 out of 524 
 
Wake Forest University
 patents
where one patent can have more than one assignee

Years Active: 2002-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Cyclopropyl Derivatives
TAK1 Kinase Inhibitors
Dirhodium Catalysts
Pyrrolidine Compounds
Tetrahydropyridines
CNS Disorders
Indoles
Erogorgiaene Congeners
Tropane Prodrugs
Enantioselective Synthesis
Metal Catalysts
Solid Support Catalysts
18 patents (USPTO):Explore Patents
1. 10207984 - Cyclopropyl derivatives and methods of use (2019-02-19),
2. 10093609 - TAK1 kinase inhibitors, compositions, and uses related thereto (2018-10-09),
3. 9751825 - TAK1 kinase inhibitors, compositions, and used related thereto (2017-09-05),
4. 8975428 - Dirhodium catalyst compositions and synthetic processes related thereto (2015-03-10),
5. 8329741 - Substituted pyrrolidine compounds with central nervous system activity (2012-12-11),
6. 7851488 - Tetrahydropyridines with central nervous system activity (2010-12-14),
7. 7851487 - Use of tetrahydropyridines in the treatment of central nervous system disorders (2010-12-14),
8. 7816536 - 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same (2010-10-19),
9. 7700798 - Erogorgiaene congeners and methods and intermediates useful in the preparation of same (2010-04-20),
10. 7550588 - Homotropanes with central nervous system activity (2009-06-23),
11. 7501453 - Cyclopropanes with central nervous system activity (2009-03-10),
12. 7432376 - Tropane prodrugs with central nervous system activity (2008-10-07),
13. 7385064 - Catalysts for use in enantioselective synthesis (2008-06-10),
14. 7109343 - Metal catalysts and methods for making and using same (2006-09-19),
15. 7030051 - Dirhodium catalyst compositions and methods for using same (2006-04-18),

Title: Innovations and Contributions of Huw M L Davies

Introduction

Huw M L Davies, a notable inventor based in Duluth, GA, United States, has made significant strides in the field of pharmaceutical compositions, holding a remarkable total of 18 patents. His inventive prowess has not only advanced medical science but also paved the way for novel treatment methods for various disorders.

Latest Patents

Among Huw M L Davies' latest accomplishments are patents that focus on cutting-edge pharmaceutical applications. One of his patents, "Cyclopropyl derivatives and methods of use," discloses various cyclopropyl derivatives aimed at managing medical conditions, including mental and mood disorders, pain, and fibromyalgia. This innovative approach utilizes pharmaceutical compositions designed for subjects in need of effective treatments.

Another notable patent, titled "TAK1 kinase inhibitors, compositions, and uses related thereto," reveals his work on TAK1 inhibitors. This patent involves compounds designed to treat or prevent cancer, showcasing innovative methods to administer effective doses of pharmaceutical compositions to affected individuals.

Career Highlights

Huw M L Davies has an impressive career, contributing his knowledge and expertise to esteemed institutions. He has worked with the Research Foundation of State University of New York and Emory University. His roles at these organizations highlight his prominent position in the research community.

Collaborations

Collaboration is essential in the realm of innovation, and Huw has worked alongside notable colleagues, including Spandan Chennamadhavuni and Andrei Bakin. These partnerships signify the collaborative effort required to address complex medical challenges through innovative solutions.

Conclusion

Huw M L Davies continues to exemplify the spirit of innovation through his extensive patent portfolio and collaborative endeavors. His contributions to the fields of pharmaceutical compositions and methods to tackle critical medical issues have the potential to transform treatment protocols, making him a distinguished figure in contemporary research and invention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…